Maybe you "trust Tylenol" or (like this writer) you're "all Advil." Research proves that both painkillers work, but many of us, including our doctors, can't help but have a preference shaped by experience and perhaps even ...
Feb 24, 2015
0
39
(HealthDay)—Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder (ADHD) symptoms in children aged 6 to 12 years, according to a study published online March 7 in the Journal ...
Mar 8, 2019
1
9
High-dose vitamin D supplementation in pediatric patients with new-onset type 1 diabetes may reduce complications, according to a study published online Aug. 18 in Frontiers in Endocrinology.
Aug 26, 2022
0
10
If you imagine in advance that something is not going to hurt, this could mean you experience less pain. This discovery was made by health psychologist Kaya Peerdeman during her Ph.D. research on the placebo effect. Ph.D. ...
Feb 6, 2018
0
289
(Medical Xpress)—A team of European researchers has found evidence that supports a theory that suggests the mechanism in the brain that controls empathy for others experiencing pain is grounded in the same mechanism that ...
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without previous cardiovascular events, aspirin did not prolong healthy, independent living (life free of dementia ...
Sep 16, 2018
0
107
Use of the EPO hormone to boost athletic performance did nothing for amateur cyclists in a road-race trial, according to a study Friday that questioned whether blood doping is worth the risk.
Jun 30, 2017
1
29
(HealthDay)—For patients with moderate to severe diabetic peripheral neuropathic pain (DPNP), transdermal buprenorphine is effective for reducing pain, but is associated with adverse events, according to a study published ...
Jul 21, 2016
0
0
Coronavirus-like particles (CoVLP), which are produced in plants, combined with an adjuvant (Adjuvant System 03 [AS03]) forms a candidate vaccine that is effective for preventing COVID-19, according to a study published online ...
May 5, 2022
0
63
Patients with multidrug-resistant HIV-1 infection receiving the capsid inhibitor lenacapavir have a greater reduction in viral load than those receiving placebo, according to a study published in the May 12 issue of the New ...
May 12, 2022
0
12
